Arginine vasopressin (AVP) related polyuria, which includes AVP-deficiency and AVP-resistance, has a prevalence of 1 per 25,000 population. Hereditary AVP-deficiency accounts for approximately 1% of all AVP-deficiency cases. Hereditary AVP-resistance has an estimated incidence of approximately 1 per 1,000,000.